Robert Browne
Family Medicine · Stockton, CANPI 1689680811
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $807 and has fallen 91.7% since, to $67 in 2023.
Across 153 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$427
- Bayer$158
- Amgen$148
- Amarin Pharma, Inc.$145
- AstraZeneca$135
- AbbVie$126
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,432100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 41 | $427 |
| Bayer | 10 | $158 |
| Amgen | 6 | $148 |
| Amarin Pharma, Inc. | 6 | $145 |
| AstraZeneca | 8 | $135 |
| AbbVie(2 entities) | 7 | $126 |
| Lilly USA, LLC | 7 | $121 |
| Pfizer | 7 | $118 |
| Boehringer Ingelheim | 4 | $105 |
| Merck | 6 | $104 |
| Avanir Pharmaceuticals, Inc. | 6 | $95 |
| Astellas Pharma US Inc | 4 | $71 |
| Collegium Pharmaceutical, Inc. | 4 | $62 |
| Corcept Therapeutics | 1 | $59 |
| Acadia Pharmaceuticals Inc | 3 | $55 |
| Novartis | 2 | $50 |
| Sunovion Pharmaceuticals Inc. | 8 | $44 |
| GSK | 2 | $42 |
| Eisai Inc. | 2 | $38 |
| UCB, Inc. | 1 | $30 |
| Sun Pharmaceutical Industries Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 2 | $21 |
| Urovant Sciences Inc | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$110
How this compares
$2,432 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Other family medicine in Stockton
- Atul VermaStockton$195K
- Daniel CooperStockton$79K
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.